Tenaya Therapeutics, Inc. (TNYA)
0.389
0.00 (0.00%)
USD |
NASDAQ |
Oct 23, 16:00
0.3897
0.00 (0.00%)
After-Hours: 20:00
Tenaya Therapeutics Net Income (Quarterly) : -43.39M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -43.39M |
| March 31, 2026 | -19.27M |
| December 31, 2025 | -20.18M |
| September 30, 2025 | -20.28M |
| June 30, 2025 | -23.28M |
| March 31, 2025 | -26.86M |
| December 31, 2024 | -23.84M |
| September 30, 2024 | -25.63M |
| June 30, 2024 | -29.43M |
| March 31, 2024 | -32.23M |
| December 31, 2023 | -29.94M |
| September 30, 2023 | -29.14M |
| June 30, 2023 | -33.27M |
| Date | Value |
|---|---|
| March 31, 2023 | -31.74M |
| December 31, 2022 | -33.52M |
| September 30, 2022 | -30.70M |
| June 30, 2022 | -28.40M |
| March 31, 2022 | -31.06M |
| December 31, 2021 | -26.15M |
| September 30, 2021 | -18.26M |
| June 30, 2021 | -15.21M |
| March 31, 2021 | -13.10M |
| December 31, 2020 | -10.32M |
| September 30, 2020 | -10.30M |
| June 30, 2020 | -8.731M |
| March 31, 2020 | -9.051M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
| Oncolytics Biotech, Inc. | -9.442M |
| Sangamo Therapeutics, Inc. | -31.00M |
| Sarepta Therapeutics, Inc. | -4.89M |
| Anixa Biosciences, Inc. | -2.625M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.11M |
| Total Expenses (Quarterly) | 44.50M |
| EPS Diluted (Quarterly) | -0.1994 |
| Enterprise Value | 13.09M |
| Gross Profit Margin (Quarterly) | -52.97% |
| Profit Margin (Quarterly) | -3.91K% |
| Earnings Yield | -135.6% |
| Normalized Earnings Yield | -116.48 |